Tag: biotech
-
Adalyon Appoints Ulrik Zeuthen as CEO to Drive Next Phase
Adalyon Names Ulrik Zeuthen as Chief Executive Officer to Lead Next Phase Espoo, Finland, Nov. 25, 2025 — Adalyon, a pioneer in AI-powered speech biomarker technology for clinical drug development, today announced the appointment of Ulrik Zeuthen as Chief Executive Officer. The move signals a strategic push to accelerate the company’s growth trajectory and advance…
-
MS Research Derailed by Stock Market Spoofing: Lawsuit Ties Manipulation to Setback
Overview: When Market Manipulation Threatens Medical Promise In a developing case that could reshape how researchers and investors view market integrity, a Canadian biotechnology company has filed a lawsuit alleging that stock spoofing—a practice where traders place and cancel orders to distort price signals—directly disrupted a potentially life-changing pathway for multiple sclerosis (MS) treatment. The…
-
Adalyon appoints Ulrik Zeuthen as CEO to drive next phase
Adalyon Announces CEO Appointment to Lead the Next Phase of Growth Adalyon, a Finnish biotech-tech firm focused on transforming clinical drug development through AI-powered speech biomarker technology, today announced the appointment of Ulrik Zeuthen as Chief Executive Officer. The leadership change signals the company’s commitment to accelerating product development, expanding strategic partnerships, and delivering on…
-
Vertex to Present at UBS Global Healthcare Conference on November 11, 2025
Vertex to Present at UBS Global Healthcare Conference on November 11, 2025 Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that its leadership will participate in the UBS Global Healthcare Conference. Reshma Kewalramani, President and Chief Executive Officer, will participate in a fireside chat on Tuesday, November 11, 2025, at 10:15 a.m. ET. The discussion will…
-
LassoESM: A New AI-Driven Path to Therapeutic Lasso Peptides
Revealing a new AI tool for lasso peptides In the race to develop novel therapeutics for cancer and infectious diseases, lasso peptides have emerged as a promising class. Their knot-like structures confer remarkable stability and diverse biological activities, making them attractive candidates for future drugs. A collaboration led by the Carl R. Woese Institute for…
-
MIT Engineers Unstick Cells on Demand With Bubble-Driven Detachment in Bioreactors
Revolutionizing cell adhesion in bioreactors and beyond MIT researchers have unveiled a scalable, high-throughput method to detach cells from surfaces on demand using electrochemically generated bubbles. Published in Science Advances, the approach could dramatically reduce downtime and waste across industries that rely on cell cultures, including algae bioreactors for carbon capture, pharmaceutical manufacturing, biofuels, biosensors,…
-
MIT Engineers Solve Sticky-cell Problem In Bioreactors And Other Industries
Introduction: A Simple Problem, Big Impact Bioreactors and related processes across industries—from algae farming in climate-friendly carbon capture efforts to manufacturing biologic drugs—face a stubborn obstacle: cells sticking to surfaces. This adhesion reduces light exposure in photobioreactors, clogs harvesting lines, and forces costly downtime for cleaning and sanitation. MIT researchers have now introduced a high-throughput,…
-
ASX Advances as Banks, Miners Lead Gains Despite Global Jitters
Australian Shares Rise as Banks and Miners Drive the Rally The Australian share market climbed on Wednesday, with the S&P/ASX 200 up 91.5 points (about 1%) to close at 8,990.90. The session followed a modest 0.2% gain on Tuesday, when mining stocks helped lift sentiment. Investors navigated a mix of domestic policy talk and international…
-
CancerVax Precision Therapy Demonstrates Liver-Sparing Potential in In-Vitro Tests
Breakthrough in Precision Cancer Therapy: Liver-Sparing in Early Studies Lehi, Utah — CancerVax, Inc., a pre-clinical biotechnology company, announced today that recent in-vitro studies demonstrate a significant reduction in liver toxicity for its universal cancer treatment platform. The findings address a long-standing challenge in oncology: protecting healthy liver tissue while delivering effective cancer-killing therapy. If…
-
MS Remyelination: New Drug Candidates Show Promise
Overview: A hopeful step toward remyelination in MS Multiple sclerosis (MS) is a chronic autoimmune disease that disrupts nerve signals when the immune system damages the myelin sheath, the protective insulation around nerve fibers. More than 2.9 million people worldwide live with MS, and symptoms can range from numbness and vision loss to paralysis. While…